Figure 2From: Incidence and risk of severe infections associated with anti-epidermal growth factor receptor monoclonal antibodies in cancer patients: a systematic review and meta-analysis Relative risk of severe infections associated with anti-EGFR MoAbs versus control. EGFR, epidermal growth factor receptor; MoAbs, monoclonal antibodies.Back to article page